DelveInsight's“Ocular melanoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Ocular melanoma, historical and forecasted epidemiology as well ...

Cancers of the eye are exceedingly rare, and only a rare handful of cancer clinics in the nation are equipped to deal with ...

It's not just a tanning obsession that has experts concerned. Eyebrows have also been raised by a technology that some say is ...

A mum-of-two has been left fighting for her life after a routine eye test revealed a devastating diagnosis.

Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling ...

It was back in 2017 when Steve Lynch first noticed a little spot on the white part (the sclera) of his right eye. “It wasn’t ...

In the highly volatile biotechnology sector, stocks can experience large fluctuations based on trial outcomes, regulatory news, and investor sentiment. However, the positive data from IMM-1-104 could ...

HB-0036 is under clinical development by Huabo Biopharm (Shanghai) and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs for Melanoma have a 27% phase transition success rate ...

FYB-206 is under development for the treatment of malignant melanoma (black skin cancer) and non-small cell lung cancer. The drug candidate is a pembrolizumab biosimilar. It acts by targeting ...

Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment ...

Australia is, unfortunately, the world leader in skin cancer of all types, and particularly the most deadly form of skin ...

One lot of Systane brand eye drops were voluntarily recalled due to possible fungal contamination, the U.S. Food and Drug Administration announced earlier this week. The affected packages of ...